Literature DB >> 34264279

Promoting Inclusion of Members of Racial and Ethnic Minority Groups in Cancer Drug Development.

Lola Fashoyin-Aje1, Julia A Beaver1, Richard Pazdur1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34264279     DOI： 10.1001/jamaoncol.2021.2137

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials-Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop.

Authors:  Darya Kizub; Cathyryne K Manner; Katy Graef; Bello Abubakar; Jackson Orem; Folakemi Odedina; Mojisola Christianah Adeyeye; Gertrude Nakigudde; Kassa Ayalew; Chitkala Kalidas; Herbert Kim Lyerly; Thea Norman; Lola Fashoyin-Aje; Jamie Freedman; Jennifer Dent; Bill Cance; Julie Gralow
Journal:  JCO Glob Oncol       Date:  2022-06

2.  FDA Approval Summary: Ivosidenib for the Treatment of Patients with Advanced Unresectable or Metastatic, Chemotherapy Refractory Cholangiocarcinoma with an IDH1 Mutation.

Authors:  Sandra J Casak; Shan Pradhan; Lola A Fashoyin-Aje; Yi Ren; Yuan-Li Shen; Yuan Xu; Edwin Chiu Yuen Chow; Ye Xiong; Jeanne Fourie Zirklelbach; Jiang Liu; Rosane Charlab; William F Pierce; Nataliya Fesenko; Julia A Beaver; Richard Pazdur; Paul G Kluetz; Steven J Lemery
Journal:  Clin Cancer Res       Date:  2022-07-01       Impact factor: 13.801

3.  Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.

Authors:  Bob T Li; Bobby Daly; Mary Gospodarowicz; Monica M Bertagnolli; Otis W Brawley; Bruce A Chabner; Lola Fashoyin-Aje; R Angelo de Claro; Elizabeth Franklin; Jennifer Mills; Jeff Legos; Karen Kaucic; Mark Li; Lydia The; Tina Hou; Ting-Hui Wu; Bjorn Albrecht; Yi Shao; Justin Finnegan; Jing Qian; Javad Shahidi; Eduard Gasal; Craig Tendler; Geoffrey Kim; James Yan; Phuong Khanh Morrow; Charles S Fuchs; Lianshan Zhang; Robert LaCaze; Stefan Oelrich; Martin J Murphy; Richard Pazdur; Kevin Rudd; Yi-Long Wu
Journal:  Nat Med       Date:  2022-04       Impact factor: 87.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.